Overview

Study A - MK0767 Monotherapy Study

Status:
Terminated
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if MK0767 lowers blood glucose after 20 weeks compared to placebo. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.